Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$902,129,131
-$100,973,389 QoQ
Shares Held
2,020,265
-8.7% QoQ
Ownership
0.796%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 63.33560201260726.ToString("F0")%
Shared 0.ToString("F0")%
None 36.664397987392746.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,683,576,696 across 351 Biotechnology names. VRTX ranks #14 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $902,129,131 | 2,020,265 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,003,102,520 | 2,212,596 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,293,887,697 | 3,303,768 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,852,116,812 | 6,406,372 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,746,293,344 | 7,727,184 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,712,509,822 | 9,219,046 | Shares | Defined | 2025-02-13 | |
| 2024-12-31 | $3,713,226,630 | 9,220,826 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,894,973,043 | 10,525,013 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,029,097,489 | 10,729,428 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,461,638,092 | 10,673,520 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,281,233,228 | 12,979,511 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,993,698,359 | 14,360,437 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,147,973,850 | 14,628,666 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,128,033,633 | 16,275,855 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $5,159,427,512 | 17,866,291 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,028,158,298 | 17,366,023 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $4,720,830,967 | 16,753,011 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,440,031,639 | 13,181,713 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,997,010,116 | 9,093,853 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $884,656,985 | 4,877,099 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $1,176,322,120 | 5,834,063 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,185,698,191 | 10,171,242 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,106,435,468 | 13,143,926 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $5,480,223,589 | 20,138,996 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,594,423,788 | 19,270,517 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $5,391,135,350 | 22,656,589 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||